Echo Therapeutics, Inc. (ECTE) Expands Patent Portfolio with Issuance of Claims for Two Key Systems
Echo Therapeutics announced today the issuance of patents covering its Prelude® SkinPrep System for transdermal drug delivery, as well as a notice of allowance for a patent for its Symphony® tCGM System, a non-invasive, wireless, transdermal continuous glucose monitoring system. Patent approval extends the company’s current patent portfolio, which is comprised of six U.S. patents; more than 60 foreign patents; and more than 30 patent applications pending, both in the U.S. and abroad. "The issuance of these patents further broadens Echo's already extensive intellectual property portfolio surrounding Prelude and Symphony and represents a valuable asset for Echo," Patrick Mooney, M.D.,…